Antipsychotic trials in schizophrenia: the CATIE project
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Cambridge [u.a.]
Cambridge Univ. Press
2010
|
| Ausgabe: | 1. publ. |
| Schriftenreihe: | Cambridge medicine
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | "Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach 20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading"--Provided by publisher. Includes bibliographical references and index |
| Beschreibung: | XVII, 312 S. graph. Darst. |
| ISBN: | 9780521895330 0521895332 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV039659356 | ||
| 003 | DE-604 | ||
| 005 | 20111130 | ||
| 007 | t | ||
| 008 | 111025s2010 xxkd||| |||| 00||| eng d | ||
| 010 | |a 2009048606 | ||
| 015 | |a GBB004291 |2 dnb | ||
| 020 | |a 9780521895330 |c hardback |9 978-0-521-89533-0 | ||
| 020 | |a 0521895332 |c hardback |9 0-521-89533-2 | ||
| 035 | |a (OCoLC)706900274 | ||
| 035 | |a (DE-599)BVBBV039659356 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxk |c GB | ||
| 049 | |a DE-355 | ||
| 050 | 0 | |a RM333.5 | |
| 082 | 0 | |a 616.89/8061 | |
| 084 | |a YH 6115 |0 (DE-625)153561:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Antipsychotic trials in schizophrenia |b the CATIE project |c edited by T. Scott Stroup ... |
| 250 | |a 1. publ. | ||
| 264 | 1 | |a Cambridge [u.a.] |b Cambridge Univ. Press |c 2010 | |
| 300 | |a XVII, 312 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Cambridge medicine | |
| 500 | |a "Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach 20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading"--Provided by publisher. | ||
| 500 | |a Includes bibliographical references and index | ||
| 610 | 2 | 4 | |a CATIE Project |
| 650 | 4 | |a Antipsychotic drugs |x Testing | |
| 650 | 4 | |a Schizophrenia |x Chemotherapy | |
| 650 | 4 | |a Schizophrenia |x drug therapy | |
| 650 | 4 | |a Antipsychotic Agents |x standards | |
| 650 | 4 | |a Antipsychotic Agents |x therapeutic use | |
| 650 | 4 | |a Clinical Trials as Topic | |
| 650 | 4 | |a Double-Blind Method | |
| 650 | 4 | |a Drug Evaluation |x methods | |
| 650 | 0 | 7 | |a Psychopharmakotherapie |0 (DE-588)4236424-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Klinisches Experiment |0 (DE-588)4164223-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Schizophrenie |0 (DE-588)4052527-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Schizophrenie |0 (DE-588)4052527-2 |D s |
| 689 | 0 | 1 | |a Psychopharmakotherapie |0 (DE-588)4236424-3 |D s |
| 689 | 0 | 2 | |a Klinisches Experiment |0 (DE-588)4164223-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Stroup, T. Scott |d 1960- |e Sonstige |0 (DE-588)143271393 |4 oth | |
| 856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024508795&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024508795 | ||
Datensatz im Suchindex
| _version_ | 1804148522022338560 |
|---|---|
| adam_text | ANTIPSYCHOTIC TRIALS IN SCHIZOPHRENIA
/ STROUP, T. SCOTT
: 2010
TABLE OF CONTENTS / INHALTSVERZEICHNIS
INTRODUCTION: RATIONALE FOR AN INDEPENDENT, PRAGMATIC STUDY OF
ANTIPSYCHOTIC TREATMENTS JEFFREY LIEBERMAN; 1. STUDY DESIGN AND PROTOCOL
DEVELOPMENT PROCESS SCOTT STROUP, JOE MCEVOY AND JEFFREY LIEBERMAN; 2.
STATISTICAL CONSIDERATIONS SONIA DAVIS AND GARY KOCH; 3. EFFICACY AND
EFFECTIVENESS JOE MCEVOY, SCOTT STROUP AND JEFFREY LIEBERMAN; 4.
MEASURES OF GLOBAL EFFECTIVENESS, COST-EFFECTIVENESS BOB ROSENHECK; 5.
QUALITY OF LIFE AND RECOVERY MARVIN SWARTZ; 6. NEUROCOGNITION RICH
KEEFE; 7. VOCATIONAL OUTCOMES SANDRA RESNICK ET AL.; 8. FAMILY OUTCOMES
DEBORAH PERLICK ET AL.; 9. NEUROLOGIC SIDE EFFECTS STAN CAROFF, DEL
MILLER AND BOB ROSENHECK; 10. METABOLIC SIDE EFFECTS AND RISK OF
CARDIOVASCULAR DISEASE JONATHAN MEYER, DON GOFF AND JOE MCEVOY; 11.
SUBSTANCE ABUSE FRED REIMHERR AND MARVIN SWARTZ; 12. VIOLENCE JEFF
SWANSON AND RICHARD VAN DORN; 13. GENETICS PATRICK SULLIVAN; 14. HUMAN
SUBJECTS CONSIDERATIONS SCOTT STROUP, SCOTT KIM AND PAUL APPELBAUM; 15.
PHARMACOKINETICS BRUCE POLLOCK; 16. IMPLICATIONS OF THE CATIE PROJECT ON
RESEARCH DESIGN AND IMPLEMENTATION SCOTT STROUP AND JEFFREY LIEBERMAN;
17. CONCLUSIONS-IMPACT OF THE STUDY AND IMPLICATIONS FOR DISSEMINATION,
PRACTICE AND POLICY FORMATION SCOTT STROUP, BOB ROSENHECK AND JEFFREY
LIEBERMAN; INDEX.
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
| any_adam_object | 1 |
| author_GND | (DE-588)143271393 |
| building | Verbundindex |
| bvnumber | BV039659356 |
| callnumber-first | R - Medicine |
| callnumber-label | RM333 |
| callnumber-raw | RM333.5 |
| callnumber-search | RM333.5 |
| callnumber-sort | RM 3333.5 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | YH 6115 |
| ctrlnum | (OCoLC)706900274 (DE-599)BVBBV039659356 |
| dewey-full | 616.89/8061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.89/8061 |
| dewey-search | 616.89/8061 |
| dewey-sort | 3616.89 48061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1. publ. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03287nam a2200589zc 4500</leader><controlfield tag="001">BV039659356</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20111130 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">111025s2010 xxkd||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2009048606</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBB004291</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780521895330</subfield><subfield code="c">hardback</subfield><subfield code="9">978-0-521-89533-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0521895332</subfield><subfield code="c">hardback</subfield><subfield code="9">0-521-89533-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)706900274</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV039659356</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxk</subfield><subfield code="c">GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM333.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.89/8061</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YH 6115</subfield><subfield code="0">(DE-625)153561:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antipsychotic trials in schizophrenia</subfield><subfield code="b">the CATIE project</subfield><subfield code="c">edited by T. Scott Stroup ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge [u.a.]</subfield><subfield code="b">Cambridge Univ. Press</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 312 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cambridge medicine</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach 20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading"--Provided by publisher.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">CATIE Project</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic drugs</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents</subfield><subfield code="x">standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Double-Blind Method</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakotherapie</subfield><subfield code="0">(DE-588)4236424-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Klinisches Experiment</subfield><subfield code="0">(DE-588)4164223-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schizophrenie</subfield><subfield code="0">(DE-588)4052527-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Schizophrenie</subfield><subfield code="0">(DE-588)4052527-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Psychopharmakotherapie</subfield><subfield code="0">(DE-588)4236424-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Klinisches Experiment</subfield><subfield code="0">(DE-588)4164223-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stroup, T. Scott</subfield><subfield code="d">1960-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)143271393</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024508795&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024508795</subfield></datafield></record></collection> |
| id | DE-604.BV039659356 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T00:08:28Z |
| institution | BVB |
| isbn | 9780521895330 0521895332 |
| language | English |
| lccn | 2009048606 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024508795 |
| oclc_num | 706900274 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | XVII, 312 S. graph. Darst. |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Cambridge Univ. Press |
| record_format | marc |
| series2 | Cambridge medicine |
| spelling | Antipsychotic trials in schizophrenia the CATIE project edited by T. Scott Stroup ... 1. publ. Cambridge [u.a.] Cambridge Univ. Press 2010 XVII, 312 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cambridge medicine "Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach 20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading"--Provided by publisher. Includes bibliographical references and index CATIE Project Antipsychotic drugs Testing Schizophrenia Chemotherapy Schizophrenia drug therapy Antipsychotic Agents standards Antipsychotic Agents therapeutic use Clinical Trials as Topic Double-Blind Method Drug Evaluation methods Psychopharmakotherapie (DE-588)4236424-3 gnd rswk-swf Klinisches Experiment (DE-588)4164223-5 gnd rswk-swf Schizophrenie (DE-588)4052527-2 gnd rswk-swf Schizophrenie (DE-588)4052527-2 s Psychopharmakotherapie (DE-588)4236424-3 s Klinisches Experiment (DE-588)4164223-5 s DE-604 Stroup, T. Scott 1960- Sonstige (DE-588)143271393 oth LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024508795&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Antipsychotic trials in schizophrenia the CATIE project CATIE Project Antipsychotic drugs Testing Schizophrenia Chemotherapy Schizophrenia drug therapy Antipsychotic Agents standards Antipsychotic Agents therapeutic use Clinical Trials as Topic Double-Blind Method Drug Evaluation methods Psychopharmakotherapie (DE-588)4236424-3 gnd Klinisches Experiment (DE-588)4164223-5 gnd Schizophrenie (DE-588)4052527-2 gnd |
| subject_GND | (DE-588)4236424-3 (DE-588)4164223-5 (DE-588)4052527-2 |
| title | Antipsychotic trials in schizophrenia the CATIE project |
| title_auth | Antipsychotic trials in schizophrenia the CATIE project |
| title_exact_search | Antipsychotic trials in schizophrenia the CATIE project |
| title_full | Antipsychotic trials in schizophrenia the CATIE project edited by T. Scott Stroup ... |
| title_fullStr | Antipsychotic trials in schizophrenia the CATIE project edited by T. Scott Stroup ... |
| title_full_unstemmed | Antipsychotic trials in schizophrenia the CATIE project edited by T. Scott Stroup ... |
| title_short | Antipsychotic trials in schizophrenia |
| title_sort | antipsychotic trials in schizophrenia the catie project |
| title_sub | the CATIE project |
| topic | CATIE Project Antipsychotic drugs Testing Schizophrenia Chemotherapy Schizophrenia drug therapy Antipsychotic Agents standards Antipsychotic Agents therapeutic use Clinical Trials as Topic Double-Blind Method Drug Evaluation methods Psychopharmakotherapie (DE-588)4236424-3 gnd Klinisches Experiment (DE-588)4164223-5 gnd Schizophrenie (DE-588)4052527-2 gnd |
| topic_facet | CATIE Project Antipsychotic drugs Testing Schizophrenia Chemotherapy Schizophrenia drug therapy Antipsychotic Agents standards Antipsychotic Agents therapeutic use Clinical Trials as Topic Double-Blind Method Drug Evaluation methods Psychopharmakotherapie Klinisches Experiment Schizophrenie |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024508795&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT strouptscott antipsychotictrialsinschizophreniathecatieproject |